Syed Ali Raza Shah | Microbiology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Syed Ali Raza Shah | Microbiology | Best Researcher Award

Assistant Professor at The University of Lahore, Pakistan

Dr. Syed Ali Raza Shah is an Assistant Professor at the University of Lahore, specializing in microbiology, infectious diseases, and immunoproteomics. He earned his PhD in Microbiology from Abdul Wali Khan University Mardan (2023) and holds an MPhil in Microbiology from Hazara University. With extensive research on Helicobacter pylori, tuberculosis, and bioinformatics, he has published multiple high-impact studies. His professional journey includes research roles at University of Malaya, IIUI, and AWKUM. Fluent in English, Urdu, and Pashto, he is skilled in technical report writing and computational tools. 📧

Publication Profile 

Google Scholar

🎓 Educational Background

Dr. Syed Ali Raza Shah holds a PhD in Microbiology & Infectious Diseases from Abdul Wali Khan University Mardan (2018-2023) 🦠. He completed his MPhil in Microbiology from Hazara University, Mansehra (2013-2015) with a 3.35/4.00 GPA 📚. His academic journey began with a BS (Hon’s) in Microbiology from the University of Peshawar (2008-2012), where he achieved a 3.37/4.00 GPA 🔬. He excelled in F.Sc (Pre-Medical) from Islamia College Peshawar (2005) with 78.8% and SSC from Islamia Collegiate School, University of Peshawar (2003) with 78.3% 🏆.

🏅 Professional Experience 

Dr. Syed Ali Raza Shah is an Assistant Professor at The University of Lahore (since February 2024) 🎓. He previously served as Visiting Faculty at Abdul Wali Khan University Mardan (2023-2024) and International Islamic University, Islamabad (2022-2023) 🏛️. He worked as a Research Associate at the University of Malaya, Malaysia (2022) and Abdul Wali Khan University Mardan (2019-2022) 🔬. His teaching career includes roles as a Lecturer at ManJanbazam Cadet College (2018-2019) and Glorious College of Sciences, Swabi (2016-2017) 📚. Additionally, he worked as a Community Science Teacher and Internee at Khyber Teaching Hospital (2012-2013) 🏥.

🔬 Research Focus of Dr. Syed Ali Raza Shah

Dr. Syed Ali Raza Shah specializes in microbiology and molecular biotechnology 🦠. His expertise includes bacterial isolation & identification, cell culture, and nucleic acid extraction 🧫. He is skilled in PCR, qPCR, and gel electrophoresis for genetic analysis 🧬. His work extends to protein extraction, SDS-PAGE, Western blotting, and immunoprecipitation for molecular diagnostics 🏥. He has experience in gene cloning, bacterial transformation, ligation, and restriction digestion for genetic engineering 🏗️. His research also covers protein purification and antibody-based assays, making significant contributions to infectious diseases, diagnostics, and molecular therapeutics 💉.

Publication Top Notes

1️⃣Novel biosynthesis, characterization and bio-catalytic potential of green algae (Spirogyra hyalina) mediated silver nanomaterials🧪🌿
Year: 2022 | Cited by: 74

2️⃣ Potential antifungal activity of different honey brands from Pakistan: a quest for natural remedy🍯🦠
Year: 2017 | Cited by: 19

3️⃣Differential Proteomics of Helicobacter pylori Isolates from Gastritis, Ulcer, and Cancer Patients: First Study from Northwest Pakistan🧬🔬
Year: 2022 | Cited by: 2

4️⃣Molecular detection of Helicobacter pylori in human saliva and biopsy samples: first report from Pakistan🦠🧫
Year: 2022 | Cited by: 2

5️⃣ Fagonia cretica: Identification of compounds in bioactive gradient high performance liquid chromatography fractions against multidrug-resistant human gut pathogens💊🧪
Year: 2022 | Cited by: 2

6️⃣ Omics finder: an android application to assist Python and omics queries📱🧬

Conclusion

Syed Ali Raza Shah is a distinguished researcher specializing in Helicobacter pylori, gastric cancer, infectious diseases, immunoproteomics, and computational biology—areas of high clinical and public health significance. His consistent publication record (2022–2025) in reputable journals reflects his active research contributions. With an interdisciplinary approach spanning molecular biology, bioinformatics, epidemiology, and computational chemistry, he demonstrates a diverse scientific profile. His collaborations with international researchers further highlight his academic influence and global research impact. Given his high-impact research, recent publications, and contributions to significant health-related fields, he is a strong candidate for the Research for Best Researcher Award. 🚀

 

Zhiliang Gao | Microbiology Award | Best Researcher Award

Posted on by ScienceFather

Prof. Zhiliang Gao | Microbiology Award | Best Researcher Award

Prof. Zhiliang Gao, Third Affiliated Hospital of Sun Yat-Sen University, China

Dr. Zhiliang Gao is a distinguished expert in infectious diseases with numerous prestigious roles and honors. He leads China’s National Excellence Courses and has received the “Special Government Allowance” and “Baosteel Outstanding Teacher Award.”📚 As Chief Physician and PhD supervisor at Sun Yat-sen University, he directs the Department of Infectious Diseases and the Emergency Treatment Center for Infectious Diseases. 🏥 Dr. Gao has received multiple accolades, including the Guangdong Science and Technology Award. 🏆 He actively contributes to national health initiatives and has published influential research in top journals like Cell and Hepatology. 📖

 

Publication profile

Scopus

Awards and Achievements 🏆

Dr. Zhiliang Gao is a trailblazer in medical education and infectious diseases. He leads China’s National Excellence Courses and has earned the “Special Government Allowance” from the State Council. 🏅 He’s been honored as the “Baosteel Outstanding Teacher” and “Famous Doctor of the Nation.” Dr. Gao has received the Guangdong Teaching Achievement Award twice and the First Prize of Guangdong Science and Technology Award. 📜 He is the editor-in-chief of the English edition of Infectious Diseases and has published pivotal research in top journals like Cell and Hepatology. 📚

Research Focus

Dr. Zhiliang Gao’s research primarily focuses on infectious diseases, with a particular emphasis on chronic hepatitis B (CHB) and its therapeutic strategies. 🦠 His work is instrumental in advancing clinical approaches towards the functional cure of CHB, as evidenced by his involvement in national programs and key publications in prominent journals. 📘 Dr. Gao’s research also explores the role of antiviral therapies and immune modulation in hepatitis B management. Additionally, he investigates the effects of drugs like tenofovir and dopamine on viral antigen expression and liver disease outcomes, contributing significantly to the field of hepatology and viral infections. 🔬

 

Publication Top Notes

  • Therapeutic strategies, practice, and prospect of a clinical cure for chronic hepatitis B in China (2024, 0 citations) 📝
    • Mo, Z.S., Xie, D.Y., Lin, B.L., Zhuang, H., Gao, Z.L., Chinese Journal of Hepatology
  • Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression (2024, 0 citations) 🧬
    • Liu, X., Pang, X., Wan, Z., Gao, Z., Deng, H., Journal of Clinical and Translational Hepatology
  • Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium (2023, 6 citations) 🌍
    • Bajaj, J.S., Choudhury, A.K., Xie, Q., Duarte Rojo, A., Cabello Negrillo, R., The Lancet Gastroenterology and Hepatology
  • Expert Consensus on the Prevention and Treatment of Hemorrhagic Fever with Renal Syndrome (2022, 4 citations) 🦠
    • Jiang, H., Huang, C., Bai, X., Wang, G., Gao, Z., Medicine (United States)
  • Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B (2021, 18 citations) 💊
    • Liu, Z., Jin, Q., Zhang, Y., Niu, J., Hou, J., Alimentary Pharmacology and Therapeutics
  • Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy (2021, 16 citations) ⚖️
    • Fan, R., Niu, J., Ma, H., Wang, G., Jiang, Y., Alimentary Pharmacology and Therapeutics
  • Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks (2021, 0 citations) 📊
    • Chen, X.-F., Fan, Y.-N., Si, C.-W., Wang, L., Dai, J., World Journal of Clinical Cases
  • Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF (2021, 17 citations) 🔬
    • Wu, Z.-B., Zheng, Y.-B., Wang, K., Yan, Y., Gao, Z.-L., Canadian Journal of Gastroenterology and Hepatology
  • Translation: Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19 (2020, 1 citation) 🏥
    • Chen, L., Chen, Y., Chen, Y., Zhang, Y., Chen, J., Infectious Microbes and Diseases
  • Functional cure of chronic hepatitis B: Efforts and prospects (2020, 5 citations) 🌟
    • Mo, Z., Gan, W., Zhao, Q., Yin, Y., Gao, Z., Liver Research

Zaineb Hamzaoui | Microbiology Award | Best Researcher Award

Posted on by ScienceFather

Dr. Zaineb Hamzaoui | Microbiology Award | Best Researcher Award

Dr. Zaineb Hamzaoui, Université Tunis el Mana, Tunisia

Dr. Zaineb Hamzaoui is a highly accomplished microbiologist with a Ph.D. from the Faculty of Sciences, Bizerte. 🎓 Her research focuses on antimicrobial resistance mechanisms, particularly in Klebsiella pneumoniae. With extensive experience in molecular biology and genomic sequencing, she currently holds a postdoctoral position at the Faculty of Medicine, Tunis. 🧬 Additionally, she contributes to academia as a part-time lecturer at the Maghreb Institute of Economic Sciences and Technology. Previously, she excelled as a Product Specialist at the African Biotechnology Society, showcasing her expertise in product development and customer engagement. 🌟

Publication Profile

Scopus

Orcid

Education

Dr. Zaineb Hamzaoui holds a Ph.D. in Biological Sciences, specializing in Microbiology, awarded in 2018 from the Faculty of Sciences, Bizerte. Her doctoral research focused on identifying carbapenem resistance mechanisms in Klebsiella pneumoniae strains isolated from the Charles Nicolle Hospital in Tunis. Prior to her Ph.D., she completed a Master’s degree in Microbiology in 2011 and a Bachelor’s degree in Life Sciences in 2008, both from Tunisian universities. Zaineb began her academic journey with a Diploma in the First Cycle of Life Sciences in 2006, following her high school graduation with a focus on Mathematics in 2004.

Professional Experience

Dr. Hamzaoui has been engaged in a Postdoctoral Contract at the Faculty of Medicine, Tunis, focusing on antimicrobial resistance research. Her responsibilities include next-generation genome sequencing of SARS-CoV-2, phenotypic and molecular studies on multi-drug resistant bacteria, and managing laboratory activities. She also serves as a part-time lecturer at the Maghreb Institute of Economic Sciences and Technology, where she prepares and delivers courses. Previously, from May 2022 to March 2023, she worked as a Product Specialist at the African Biotechnology Society, specializing in product training, marketing, and customer engagement strategies. 🧬📚

Research Focus

Dr. Zaineb Hamzaoui’s research primarily focuses on antimicrobial resistance in various pathogens, with a particular emphasis on Gram-negative bacteria. 🦠 Her contributions span extensive studies on the molecular mechanisms underlying resistance, including the characterization of carbapenemases and plasmid-mediated resistance genes. She has investigated the prevalence of multidrug-resistant strains in healthcare settings, highlighting the urgent need for effective infection control measures. Additionally, her work extends to understanding the dynamics of antimicrobial resistance in community settings, shedding light on the dissemination of resistant bacteria among vulnerable populations. Overall, Dr. Hamzaoui’s research endeavors aim to inform strategies for combating the growing threat of antimicrobial resistance. 🌐

Publication Top Notes 
  1. Extensively drug-resistant Acinetobacter baumannii co-producing VIM-2 and OXA-23 in intensive care units: Results of a one-day point prevalence in a Tunisian hospital” – Infectious Diseases Now, 2022.
  2. “Escherichia coli colonizing healthy children in Tunisia: High prevalence of extra-intestinal pathovar and occurrence of non-extended-spectrum-β-lactamase-producing ST131 clone” – International Journal of Antimicrobial Agents, 2018.
  3. “First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated blaNDM-1 in a Tunisian intensive care unit” – International Journal of Antimicrobial Agents, 2018.
  4. “NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia” – International Journal of Antimicrobial Agents, 2018.
  5. “Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae” – International Journal of Antimicrobial Agents, 2018.
  6. “An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia” – Microbial Drug Resistance, 2018.
  7. “Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm” – International Journal of Food Microbiology, 2018.
  8. “Rectal Carriage of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram-Negative Bacilli in Intensive Care Units in Tunisia” – Microbial Drug Resistance, 2017.
  9. “Community fecal carriage of broad-spectrum cephalosporin-resistant Escherichia coli in Tunisian children” – Diagnostic Microbiology and Infectious Disease, 2017.
  10. “High Prevalence of Gut Microbiota Colonization with Broad-Spectrum Cephalosporin Resistant Enterobacteriaceae in a Tunisian Intensive Care Unit” – Frontiers in Microbiology, 2016.

THANH TRANCHAU MY | Microbiology Award | Young Scientist Award

Posted on by ScienceFather

Dr. THANH TRANCHAU MY | Microbiology Award | Young Scientist Award

Dr. THANHTRAN CHAU MY, DUYTAN UNIVERSITY, Vietnam

👩‍🎓 Dr. THANHTRAN CHAU MY, a graduate of Hue University of Medicine and Pharmacy, Vietnam, holds a Master’s degree (MD.) in Medicine from the same institution. With a diverse skill set, she excels in teaching Molecular Pathology, Molecular Biology, Biochemistry, and Microbiology to undergraduates. Dr. CHAU MY is adept at training students and staff in various lab techniques and thesis writing. Her expertise extends to molecular biochemical assays and departmental management. Notably, she has contributed significantly to academia with three publications in esteemed journals indexed in ISI/Scopus (Q1, Q2) between 2023 and 2024, marking her commitment to advancing medical science.

 

Publication Profile

Google Scholar

Education and Experience

🎓 Dr. THANH TRANCHAU MY holds a Doctorate from Hue University of Medicine and Pharmacy, Vietnam, specializing in Medicine. Additionally, she attained a Master’s degree (MD.) in Medicine from the same institution. Her academic journey has equipped her with a comprehensive understanding of medical principles and practices.

Teaching 

Dr. THANH TRANCHAU MY has been instrumental in teaching undergraduate students various subjects including Molecular Pathology, Molecular Biology, Biochemistry, and Microbiology. Her expertise extends to training new staff and undergraduates in laboratory techniques and thesis writing, fostering a dynamic learning environment.

Academic Achievements

🏆 Dr. THANH TRANCHAU MY’s scholarly contributions include the publication of three articles in prestigious journals indexed in ISI/Scopus (Q1, Q2) between 2023 and 2024. Her research prowess underscores her commitment to advancing medical knowledge and practice.

Research Focus

🔬 Dr. THANH TRANCHAU MY research primarily focuses on molecular mechanisms underlying cardiovascular diseases, particularly coronary heart disease and ischemic cardiomyopathy. His work explores the intricate interactions between circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) to unravel potential biomarkers and therapeutic targets. With a keen interest in bioinformatics analysis, Dr. Dinh identifies serum microRNAs with diagnostic potential across various cancer types. Through his publications, he contributes significantly to understanding disease progression and developing novel strategies for diagnosis and treatment, marking his dedication to advancing cardiovascular research and bioinformatics analysis.

 

Publication Top Notes 

 

Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

Alemayehu Choramo | Microbiology | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Alemayehu Choramo | Microbiology | Best Researcher Award

Assist Prof Dr. AlemayehuChoramo, Bonga university, Ethiopia

👨‍🔬 Dr. Alemayehu Choramo brings a wealth of experience and expertise to the field of veterinary medicine. With a background spanning from animal health work in Tocha Wereda to leadership roles at Bonga University, Ethiopia, he has demonstrated his commitment to advancing animal welfare and education. Holding a Doctor of Veterinary Medicine (DVM) and an MSc in Veterinary Microbiology from Jimma University, his academic prowess is evident. Proficient in languages including Amharic, English, Afan Oromo, Dawrogna, and Wolaitegna, Dr. Choramo’s multilingual skills facilitate effective communication across diverse communities. 🐾📚

Publication Profile:

Orcid

Google Scholar

 

Education Background:

Dr. Alemayehu Choramo’s educational journey is a testament to his dedication to veterinary medicine. He commenced his academic pursuits at Tocha Senior Secondary School in Tocha Woreda, Dawro Zone, SNNPR, Ethiopia, completing his secondary education in September 200*. Subsequently, he pursued his preparatory education at Waka Senior Secondary and Preparatory School in Mareka Woreda, Dawro Zone, further laying the foundation for his future academic endeavors.His passion for veterinary science led him to Jimma University, where he embarked on his higher education journey, earning his Doctor of Veterinary Medicine (DVM) degree. During his time at Jimma University, he demonstrated exceptional academic performance, graduating with a commendable CGPA.Continuing his pursuit of knowledge, Dr. Choramo pursued a Master of Science (MSc) degree in Veterinary Microbiology at Jimma University from October 2017 to June 2020. His dedication to his studies and research in this specialized field reflects his commitment to advancing veterinary medicine. With each milestone, Dr. Choramo’s expertise and understanding of animal health deepened, preparing him for his impactful career ahead in veterinary medicine. 🎓🐾

Work Experience:

👨‍⚕️ Dr. Alemayehu Choramo’s professional journey reflects his unwavering commitment to the betterment of animal health and education. Beginning as an animal health worker in Tocha Wereda, Dawro Zone, Ethiopia, he dedicated three years to serving his community, fostering vital skills and insights into the field. Transitioning seamlessly into academia, he assumed the role of Assistant Professor at Bonga University in March 2020. Here, his passion for teaching and research found a platform to flourish, impacting the next generation of veterinary professionals. His leadership qualities and expertise were soon recognized, leading to his appointment as the Head of the Department of Veterinary Medicine at Bonga University in October. In this role, Dr. Choramo plays a pivotal role in shaping the department’s vision, fostering innovation, and ensuring academic excellence. Through his combined experiences in practical animal health work and academia, he brings a holistic perspective to his leadership, driving initiatives that bridge theory and practice in veterinary medicine. Dr. Choramo’s dedication to advancing the field, coupled with his compassionate approach, continues to inspire both colleagues and students alike. 🐾🏫

Research Focus:

🔬 Dr. Alemayehu Choramo’s research focus spans across various domains within veterinary medicine and molecular biology. Primarily, his work delves into antimicrobial activity, emphasizing the utilization of ethnoveterinary medicinal plants to combat infections. Additionally, he explores parasitology, particularly the prevalence of diseases like babesiosis in cattle populations. Dr. Choramo also contributes significantly to molecular biology, with studies on RNA interference, gene regulation, and recombinant DNA technology, showcasing his interest in cutting-edge genetic research. Through his diverse contributions, he aims to advance understanding and application in both traditional and modern approaches to animal health and molecular biology. 🌱🧬

Publication Top Notes:

Antimicrobial Activity of Selected Ethnoveterinary Medicinal Plants of Southern Region, Ethiopia

Prevalence of Babesiosis in Cattle in and Around Jimma Town, OromiaRegion, South Western Ethiopia

Laboratory Practical Work on Colony Count, Motility Test and Antimicrobial Susceptibility Test

Serological detection of Newcastle disease virus in backyard poultry production system in Woliso District South West Shewa, Central Ethiopia

A Review on Chemical and Physical Methods of Controlling Microbial Growth